Lars Søndergaard

Lars Søndergaard

Lars Søndergaard, MD, DMSc

Bio

Consultant Cardiologist, Rigshospitalet, Copenhagen, Denmark

Professor of Cardiology, University of Copenhagen, Denmark

Graduate in 1988 from University of Copenhagen. Trained in cardiology at Rigshospitalet in Copenhagen, as well as Great Ormond Street Hospital for Sick Children and The Heart Hospital in London. Special interest in congenital and structural heart diseases, particular interventional procedures, and Head of these programs at Rigshospitalet in Copenhagen. Lead the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012. Furthermore, first-in-human implantation for the Gore Septal Occluder (2011), Inter Atrial Septal Device (Corvia) for HFpEF (2012), Hydra transcatheter aortic valve prosthesis (2013), and Lotus transcatheter aortic valve DepthGuard system (2016)

Professor of Cardiology at University of Copenhagen since 2015. His thesis ‘Quantitative assessment of aortic regurgitation and stenosis using magnetic resonance velocity mapping: Technical aspects and clinical evaluation’ was awarded with a DMSc degree from University of Copenhagen. Published 189 peer reviewed articles, and 14 text book chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions. Lead principal investigator for several trials including the NOTION-1 and NOTION-2 randomised trials (investigating the role of transcatheter aortic valve replacement younger, lower risk patients with aortic stenosis), NOTION-3 randomised trial (re-vascularization before TAVI), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).

By | 2018-04-06T17:36:11+00:00 April 6th, 2018|Uncategorized|Comments Off on Lars Søndergaard

About the Author: